CD4分子(CD4)重组抗体

Recombinant Antibody to Cluster Of Differentiation 4 (CD4)

CD4mut; p55; T-cell surface glycoprotein CD4; T-cell surface antigen T4/Leu-3

  • CD4分子(CD4)重组抗体产品包装(模拟)
  • CD4分子(CD4)重组抗体产品包装(模拟)
  • RAB167Hu21.jpgFigure. Western Blot; Sample: Recombinant Human CD4.
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对CD4的小鼠单克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别CD4。

用法

免疫印迹:0.2-2µg/mL;1:500-5000
免疫组织化学:5-20µg/mL;1:50-200
免疫细胞化学:5-20µg/mL;1:50-200
最佳稀释倍数最终由用户决定。

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

赠品

相关产品

编号适用物种:Homo sapiens (Human,人)应用(仅供研究使用,不用于临床诊断!)
RPB167Hu01CD4分子(CD4)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAB167Hu01CD4分子(CD4)多克隆抗体WB; IHC; ICC; IP.
FAB167Hu01抗CD4分子(CD4)多克隆抗体Flow cytometry.
LAB167Hu71CD4分子(CD4)多克隆抗体(生物素标记)WB; IHC; ICC.
FAB167Hu41抗CD4分子(CD4)多克隆抗体(藻红素标记)Flow cytometry.
FAB167Hu51抗CD4分子(CD4)多克隆抗体(别藻蓝蛋白标记)Flow cytometry.
FAB167Hu81抗CD4分子(CD4)多克隆抗体(异硫氰酸荧光素标记)Flow cytometry.
MAB167Hu22CD4分子(CD4)单克隆抗体WB; IHC; ICC; IP.
RAB167Hu22CD4分子(CD4)重组抗体WB; IF; ICC; IHC; IP; FCM.
MAB167Hu23CD4分子(CD4)单克隆抗体WB; IHC; ICC; IP.
MAB167Hu24CD4分子(CD4)单克隆抗体WB; IHC
MAB167Hu26CD4分子(CD4)单克隆抗体WB; IHC; ICC; IP.
MAB167Hu27CD4分子(CD4)单克隆抗体WB; IHC; ICC; IP.
MAB167Hu21CD4分子(CD4)单克隆抗体WB; IHC; ICC; IP.
RAB167Hu21CD4分子(CD4)重组抗体WB; IHC; ICC.
MAB167Hu25CD4分子(CD4)单克隆抗体WB; IHC; ICC; IP.
FAB167Hu02抗CD4分子(CD4)单克隆抗体Flow cytometry.
FAB167Hu42抗CD4分子(CD4)单克隆抗体(藻红素标记)FCM
FAB167Hu52抗CD4分子(CD4)单克隆抗体(别藻蓝蛋白标记)Flow cytometry.
FAB167Hu82抗CD4分子(CD4)单克隆抗体(异硫氰酸荧光素标记)Flow cytometry.
SEB167HuCD4分子(CD4)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMB167HuCD4分子(CD4)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.
KSB167Hu01CD4分子(CD4)检测试剂盒DIY材料(酶联免疫吸附试验法)Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志参考文献
Taylor & FrancisInfluences of Hyriopsis cumingii polysaccharides on mice immunosignaling molecules and T lymphocyte differentiation[09540105.2017.1306494]
anticancer researchAdjuvant Postoperative CD40 Agonist and PD-1 Antagonist Combination Therapy in Syngeneic Tongue Cancer Mouse Model[Pubmed: 32366416]